Tadalafil as an Adjuvant to Therapy for Duchenne Muscular Dystrophy
Latest Information Update: 06 Mar 2025
At a glance
- Drugs Tadalafil (Primary)
- Indications Duchenne muscular dystrophy
- Focus Therapeutic Use
Most Recent Events
- 27 Feb 2025 Planned End Date changed from 20 Jan 2025 to 5 Sep 2025.
- 27 Feb 2025 Planned primary completion date changed from 20 Jan 2025 to 5 Sep 2025.
- 06 Nov 2024 Planned primary completion date changed from 20 Oct 2024 to 20 Jan 2025.